Related Articles
Antitumor effects and molecular mechanisms of action of natural products in ovarian cancer (Review)
Tumor microenvironment manipulates chemoresistance in ovarian cancer (Review)
Epithelial ovarian cancer: Second and third line chemotherapy (Review)
Cisplatin and platinum drugs at the molecular level (Review)
Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor